Monitor peptide, also known as pancreatic secretory trypsin inhibitor I (PSTI-I) or pancreatic secretory trypsin inhibitor 61 (PSTI-61), is a peptide that plays an important role in the regulation of the digestive system, specifically the release of cholecystokinin (CCK).[1][2][3][4]
- ^ Shlomo Melmed, M.M.; Polonsky, K.S.; P. Reed Larsen, M.D.F.; Kronenberg, H.M. (2015). Williams Textbook of Endocrinology. Internal Medicine. Elsevier Health Sciences. p. 1714. ISBN 978-0-323-29738-7. Retrieved 2023-03-25.
- ^ Yamanishi, Rintaro; Kotera, Jun; Fushiki, Tohru; Soneda, Tomoko; Iwanaga, Toshihiko; Sugimoto, Etsuro (1993). "Characteristic and Localization of the Monitor Peptide Receptor". Bioscience, Biotechnology, and Biochemistry. 57 (7). Informa UK Limited: 1153–1156. doi:10.1271/bbb.57.1153. ISSN 0916-8451.
- ^ Graf, R.; Klauser, S.; Fukuoka, S.-I.; Schiesser, M.; Bimmler, D. (2003). "The Bifunctional Rat Pancreatic Secretory Trypsin Inhibitor/Monitor Peptide Provides Protection against Premature Activation of Pancreatic Juice". Pancreatology. 3 (3). Elsevier BV: 195–206. doi:10.1159/000070729. ISSN 1424-3903.
- ^ Miyasaka, Kyoko; Nakamura, Rieko; Funakoshi, Akihiro; Kitani, Kenichi (1989). "Stimulatory Effect of Monitor Peptide and Human Pancreatic Secretory Trypsin Inhibitor on Pancreatic Secretion and Cholecystokinin Release in Conscious Rats". Pancreas. 4 (2). Ovid Technologies (Wolters Kluwer Health): 139–144. doi:10.1097/00006676-198904000-00001. ISSN 0885-3177.